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Tularemia is a zoonotic, highly infectious disease 
caused by an intracellular Gram-negative bacterium, 
Francisella tularensis. The disease affects a wide range 
of hosts including invertebrates, mammals and birds. 
Humans can become infected by direct contact with an 
infected animal (through broken skin, scratch or tissue 
injury), through a bite of haematophagous arthropods 
(e.g. fleas, lice, midges, bedbugs, mosquitoes, ticks), 
by drinking contaminated water, eating contaminated 
food, or through inhalation of contaminated dust 
(Formińska et al., 2015). The clinical presentation in 
humans depends on the route of infection and varies 
in symptoms and severity (Eliasson et al., 2006). There 
are four subspecies of F. tularensis: tularensis, novicida, 
mediasiatica and holarctica. Of these, subsp. tularensis 
and subsp. holarctica cause disease in humans, whereas 
subsp. mediasiatica is believed to be of relatively low 
virulence in humans, and only rare cases of human dis-
ease caused by this subspecies are known. F. tularensis 
subsp. novicida is non-pathogenic for humans (Celli 
and Zahrt, 2013).
According to WHO case definition, a confirmation 
of tularemia case requires recovery of an isolate and 
identification of the culture as F. tularensis by antigen or 
DNA detection. Commercial biochemical identification 
systems available in clinical diagnostic laboratories are 
not suitable for accurate identification of F. tularensis. 
Alternatively, paired serum specimens with a fourfold 
difference in titre (tube or microagglutination assay) 
or significantly (ELISA), with at least one serum posi-
tive, are also considered confirmatory (WHO, 2007). 
However, antibody against F. tularensis are detectable in 
patients’ serum 10–20 days post-infection (Koskela and 
Salminen, 1985). Thus, usefulness of antibody detec-
tion tests is limited in severe cases and when a rapid 
preventive action must be undertaken. On the other 
hand, a F. tularensis antiserum (Becton Dickinson Diag-
nostic Systems) recommended by WHO for the slide 
agglutination test for F. tularensis culture identifica-
tion has been withdrawn from the manufacturer’s offer 
and is not available on the market any more. Below 
we described the latex agglutination test (LAT) for the 
rapid identification of F. tularensis isolates that could be 
an alternative for the classical slide agglutination test. 
For the preparation of sera for coating of latex 
beads we used pooled serum samples obtained from 
25 patients with high level of IgM antibodies to F. tula-
rensis, specified as OD450 higher than 1,80 by ELISA 
(Rastawicki and Wolaniuk, 2013; Rastawicki et al., 
2015). The gamma globulin fractions of sera were iso-
lated by 40% ammonium sulfate fractionation in cold-
bath, and the precipitate was resuspended in phos-
phate-buffered saline (PBS), pH 7.4. The solution was 
subsequently dialyzed against PBS for 48 hours until 
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ammonium sulfate had been removed. Then, 5.0 ml 
of washed, 1% suspension of 0,81 µm latex particles 
in glycine-saline buffer (pH 8.2) was added to equal 
volume of twice-diluted in glycine-saline buffer puri-
fied gamma globulins. The mixture was vortexed for 
1 min and then allowed to incubate with gentle stirring 
at 37°C for 6 h. After incubation, sensitized latex par-
ticles were recovered by centrifugation, washed twice 
with glycine-buffered saline and finally diluted to 1% 
with glycine-buffered saline (pH 8.2) containing 0.1% 
sodium azide and 0.3% of BSA. For control, the latex 
reagent particles were sensitized with bovine albumin 
(Sigma Chemical Co., USA).
The investigated strains of F. tularensis (Table I) 
were cultured on enriched chocolate agar plates. After 
48 h of incubation, a small loopful of bacteria from the 
strain investigated was suspended in 100 µl of PBS. The 
latex particles sensitized with gamma globulins and the 
particles sensitized with albumin bovine-control latex 
reagent, were parallel mixed with the same volume 
(25 µl) of bacterial suspensions on a black glass plate. 
The results were read after 1, 3 and 5 minutes of rocking 
the plate. Agglutination (clumping of cells) was scored 
as: -negative; +/++/+++ weak/strong/very strong posi-
tive. A positive latex agglutination test and a negative 
latex control test were confirmatory for F. tularensis. To 
assess potential cross-reactivity of the developed latex 
test we used the 16 different control bacterial strains 
as presented in Table  I. The procedures of LAT with 
control strains were the same as for F. tularensis.
All manipulations with viable F. tularensis strains 
were done under biosafety level 3 (BSL-3) conditions. 
Keeping in mind that most diagnostic laboratories 
work under BSL-2 conditions, to minimize the risk of 
infection we also evaluated the test using inactivated 
bacterial suspension. For inactivation the bacterial sus-
pension in PBS was heated at 96°C for 15 min, then 
cooled and used for the LAT. To verify the effectiveness 
of inactivation, 50 µl of the suspension were inoculated 
onto enriched chocolate agar plates and incubated at 
37°C for 10 days. 
The agglutination reactions with F. tularensis subsp. 
holarctica and F. tularensis subsp. tularensis strains 
after 3  minutes were very strong without any differ-
ences between live and inactivated suspensions used. 
We did not observe positive reactions for F. tularensis 
with the control latex reagent. No positive reactions 
were observed also by the LAT with F. tularensis subsp. 
novicida as well as with the most of control strains. 
However, a very strong reaction of LAT with S. aureus 
Francisella tularensis ssp. holarctica A 104-15 + +++ +++
Francisella tularensis ssp. holarctica LVS + +++ +++
Francisella tularensis ssp. tularensis Ft33 + +++ +++
Francisella tularensis ssp. novicida Ft26 – – –
Yersinia enterocolitica ATCC 23715 – – –
Shigella sonnei WHO SH 16-1 – – –
Serratia marcescens ATCC 14756 – – –
Pseudomonas aeruginosa ATCC 27853 – – –
Salmonella Enteritidis ATCC 13076 – – –
Salmonella Typhimurium ATCC 14028 – – –
Proteus vulgaris ATCC 6380 – – –
Escherichia coli ATCC 25922 – – –
Acinetobacter baumannii ATCC BAA-1605 – – –
Enterobacter cloacae ATCC BAA-1143 – – –
Staphylococcus aureus ATCC 25923 + +++ +++
Staphylococcus aureus – clinical strain 1/2017 – – +
Staphylococcus aureus – clinical strain 2/2017 – + ++
Staphylococcus aureus – clinical strain 3/2017 – + ++
Staphylococcus aureus – clinical strain 4/2017 – – +
Staphylococcus aureus – clinical strain 5/2017 – – –
Table I
Bacterial strains used in the study and results of the latex agglutination test (LAT)
after 1, 3 and 5 minutes of rocking.
* – negative; +/++/+++ weak/strong/very strong positive
Microorganism
Result of latex agglutination test*
1 min 3 min 5 min
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ATCC 25923 was found after 3 minutes of rocking the 
plates. For this reason, we decided to investigate the 
additional five S. aureus strains isolated from hospi-
tal patients. A weak positive reaction after 3 minutes 
and a strong reaction after 5 minutes of rocking were 
observed in two cases. 
Antibody coated latex particles are commonly used 
in diagnostic microbiology for detection, identifica-
tion or serotyping of many different microbes (Miller 
et al., 2008; Porter et al., 2008; Sumithra et al., 2013). 
In the previous work we developed the LAT for detec-
tion of antibodies against F. tularensis in serum samples 
(Rastawicki et al., 2015). Here, we present the LAT for 
identification of F. tularensis that could be cultured from 
all kinds of samples like environmental, food, human 
and animal tissue samples, etc. In accordance with our 
expectation, the test recognized F. tularensis subsp. tula-
rensis and F. tularensis subsp. holarctica but not F. tula-
rensis subsp. novicida. It is because of the unique LPS 
composition of both subsp. tularensis and subsp. holarc-
tica, which is different from that of F. tularensis subsp. 
novicida (McLendon et al., 2006). The LAT recognises 
clinically relevant subspecies of F. tularensis, opposite to 
PCR detection of tul4 gene, which gives positive results 
for all Francisella species and additional PCRs for other 
targets are necessary to differentiate Francisella species 
and subspecies (WHO, 2007). The lack of cross-reac-
tivity of the LAT with other bacteria, except S. aureus, 
is in accordance with other researchers’ results on anti-
body-based F. tularensis identification methods such as 
cELISA and immunochromatographic assay (Grunow 
et al., 2000), and reveals that the test is highly specific. 
The cross-reactivity with some S. aureus strains is prob-
ably related to the presence of protein A in the cell wall 
of these S. aureus strains. It has been demonstrated that 
protein A expressed by some S. aureus strains has a high 
ability to bind immunoglobulins (King and Wilkinson, 
1981; Romagnani et al., 1981). Our experiments with 
other latex tests of different commercial companies, for 
example dedicated to detection of Salmonella or E. coli 
strains, also showed cross-reactivity with some S. aureus 
(data not shown). However, it is quite easy to differenti-
ate between F. tularensis and S. aureus based on com-
mercially available latex agglutination test for S. aureus 
or ability to grow on various microbiological media, 
the colonial morphology, or Gram staining. F. tularen-
sis grows on rich media (enriched chocolate agar – CA, 
buffered charcoal yeast extract – BCYE, cystine heart 
agar with 9% choco latized blood – CHAB, thioglycol-
late-glucose blood agar – TGBA, GC Agar II with 1% 
haemoglobin and 1% IsoVitaleX, sheep blood agar – SA) 
but does not grow on ordinary media; whereas, S. aureus 
easily grows on ordinary media such as nutrient agar 
(NA) and brain heart infusion agar (BHI). Also, some 
selective media can be applied.
The LAT developed in our study is inexpensive, sim-
ple, rapid and does not need any specialized equipment 
to be performed. We recommend that the results should 
be read after 3 minutes of rocking the plate. Thus, the 
test can be performed much faster compared to PCR 
or real-time PCR which needs at least one hour, even 
when the fast polymerases are used (Zasada et al., 2013). 
Moreover, the test works well with inactivated samples 
which minimizes the risk of laboratory acquired infec-
tion and allows to perform the test under BSL-2 condi-
tions. It is the important characteristic as majority of 
diagnostic laboratories work under BSL-2 conditions 
with no access to a BSL-3 laboratory. The LAT reagents 
shelf life is at least 2 years when stored at 4°C, as it was 
shown by manufacturers of commercially available latex 
tests for other microbes as well as our experience with 
in-house tests. The method is also highly reproducible 
between different operators (data not shown). The LAT 
could be an alternative for the slide agglutination test 
described in WHO guidelines for tularemia (WHO, 
2007) when the Francisella tularensis antiserum is una-
vailable. Moreover, the use of latex particles coated with 
antibodies increases sensitivity of antigen detection sig-
nificantly when compared to the slide agglutination test 
with antiserum (Drożdż, 2006).
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